{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:50:29Z","timestamp":1777866629747,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002641","name":"Konkuk University - Seoul Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.virusres.2021.198342","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T04:58:33Z","timestamp":1613537913000},"page":"198342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus"],"prefix":"10.1016","volume":"296","author":[{"given":"Dong-Hwi","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Seop","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Jeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong-Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Seon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-6571","authenticated-orcid":false,"given":"In-Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2021.198342_bib0005","series-title":"Application of RNA Interference Methodology to Inhibit Avian Influenza Virus Replication in Vitro","author":"Abrahamyan","year":"2008"},{"key":"10.1016\/j.virusres.2021.198342_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s001090050236","article-title":"Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells","volume":"76","author":"Acsadi","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.virusres.2021.198342_bib0015","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-\u03bb\/IL-28) in TLR-Induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2021.198342_bib0020","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virusres.2021.198342_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/smim.1998.0138","article-title":"Role of early cytokines, including alpha and beta interferons (IFN-\u03b1\/\u03b2), in innate and adaptive immune responses to viral infections","volume":"10","author":"Biron","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.virusres.2021.198342_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800219","article-title":"Leaky expression of the TET-On system hinders control of endogenous miRNA abundance","volume":"14","author":"Costello","year":"2019","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.virusres.2021.198342_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15252\/emmm.201606413","article-title":"IFN\u03bb is a potent anti\u2010influenza therapeutic without the inflammatory side effects of IFN \u03b1 treatment","volume":"8","author":"Davidson","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.virusres.2021.198342_bib0040","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon \u03b1, \u03b2, or \u03b3 using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2021.198342_bib0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2011.02.023","article-title":"Antiviral activity of bovine type III interferon against foot-and-mouth disease virus","volume":"413","author":"D\u00edaz-San Segundo","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2021.198342_bib0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/jir.2014.0009","article-title":"Functional characterization of canine interferon-lambda","volume":"34","author":"Fan","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virusres.2021.198342_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2019.07.007","article-title":"Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by type I and type III interferons","volume":"51","author":"Forero","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2021.198342_bib0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2021.198342_bib0065","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R110.145839","article-title":"Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity","author":"Haller","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2021.198342_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetimm.2013.09.013","article-title":"Antiviral and antiproliferative effects of canine interferon-\u03bb1","volume":"156","author":"Ichihashi","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.virusres.2021.198342_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2016-0174OC","article-title":"The superiority of IFN-l as a therapeutic candidate to control acute influenza viral lung infection","volume":"56","author":"Kim","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.virusres.2021.198342_bib0080","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33354","article-title":"IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.virusres.2021.198342_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2017.08.006","article-title":"Type I interferons in the pathogenesis and treatment of canine diseases","author":"Klotz","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.virusres.2021.198342_bib0090","doi-asserted-by":"crossref","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virusres.2021.198342_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2015.10.021","article-title":"IFN-lambda therapy: current status and future perspectives","author":"Lasfar","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.virusres.2021.198342_bib0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/pharmaceutics3030338","article-title":"Adenovirus vector-derived VA-RNA-Mediated innate immune responses","volume":"3","author":"Machitani","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virusres.2021.198342_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004782","article-title":"Leukocyte-derived IFN-\u03b1\/\u03b2 and epithelial IFN-\u03bb constitute a compartmentalized mucosal defense system that restricts enteric virus infections","volume":"11","author":"Mahlak\u00f5iv","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2021.198342_bib0110","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1074\/mcp.RA118.000735","article-title":"Comprehensive proteomics identification of IFN\u03bb3-regulated antiviral proteins in HBV-transfected cells","volume":"17","author":"Makjaroen","year":"2018","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.virusres.2021.198342_bib0115","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198342_bib0120","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hep.23743","article-title":"Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection","volume":"52","author":"Muir","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2021.198342_bib0125","series-title":"Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors","article-title":"A critical risk factor for a major side effect of interferon-alpha therapy: activated indoleamine 2,3-dioxygenase 1 is related to depressive symptoms","author":"Murakami","year":"2018"},{"key":"10.1016\/j.virusres.2021.198342_bib0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00705-015-2395-1","article-title":"Analysis of cytokine production in a newly developed canine tracheal epithelial cell line infected with H3N2 canine influenza virus","volume":"160","author":"Park","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2021.198342_bib0135","doi-asserted-by":"crossref","DOI":"10.1038\/nri1153","article-title":"Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators","author":"Renauld","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2021.198342_bib0140","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virusres.2021.198342_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2021.198342_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2893.2010.01393.x","article-title":"Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update","volume":"18","author":"Sockalingam","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2021.198342_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2018.08.002","article-title":"History of matrix genes mutations within PCR target regions among circulating influenza H3N2 clades over ten-plus-years","volume":"107","author":"Stellrecht","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virusres.2021.198342_bib0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fmicb.2015.00228","article-title":"Global and quantitative proteomic analysis of dogs infected by avian-like H3N2 canine influenza virus","volume":"6","author":"Su","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2021.198342_bib0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.gt.3301949","article-title":"Adenovirus-mediated gene transfer of interferon \u03b1 improves dimethylnitrosamine-induced liver cirrhosis in rat model","volume":"10","author":"Suzuki","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2021.198342_bib0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2021.198342_bib0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2007.07.024","article-title":"Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha","volume":"369","author":"Wu","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2021.198342_bib0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biopha.2017.01.077","article-title":"Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation","volume":"88","author":"Yan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.virusres.2021.198342_bib0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.micpath.2017.10.047","article-title":"Identification and function analysis of canine stimulator of interferon gene (STING)","volume":"113","author":"Zhang","year":"2017","journal-title":"Microb. Pathog."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:12:16Z","timestamp":1759155136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"alternative-id":["S0168170221000496"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198342","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198342"}}